Nuclear expression of histone deacetylases and their histone modifications predicts clinical outcome in colorectal cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|66|2|270-282

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.66, Iss.2, 2015-01, pp. : 270-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone deacetylases (HDACs) in frontotemporal lobar degeneration

By  

NEUROPATHOLOGY & APPLIED NEUROBIOLOGY, Vol. 41, Iss. 2, 2015-02 ,pp. : 245-257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Significance of Histone Deacetylase 1 Expression in Patients with Hepatocellular Carcinoma

By  

Oncology, Vol. 72, Iss. 1-2, 2007-11 ,pp. : 69-74

Karger

Access to resources Recommend Favorite

Targeting histone deacetylases (HDACs) and Wee1 for treating high‐risk neuroblastoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 1, 2015-01 ,pp. : 52-59

John Wiley & Sons Inc

Access to resources Recommend Favorite

Histone Post-Translational Modifications in DNA Damage Response

By  

Cytogenetic and Genome Research, Vol. 128, Iss. 1-3, 2010-04 ,pp. : 28-36

Karger

Access to resources Recommend Favorite

Clinical Significance of Nuclear Morphometry at the Invasive Front of T1 Colorectal Cancer and Relation to Expression of VEGF-A and VEGF-C

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 230-238

Karger

Access to resources Recommend Favorite